Such collaboration between IL-21 and IFN-γ also provides mechanisms by which the IL-21/IL-21R signaling axis regulates inflammation in the colon and provides insights into novel preventive and therapeutic targets for inflammatory conditions in humans, including inflammatory bowel disease, as well as inflammation-induced cancers. Here, IL21 is linked to inflammatory bowel disease.